Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




WEF Selects Transasia Bio-Medicals for Global Growth Company Award

By LabMedica International staff writers
Posted on 08 Jan 2015
Leading in vitro diagnostics (IVD) company Transasia Bio-Medicals Ltd. More...
(Mumbai, India) has been selected as “Global Growth Company-2014” by the World Economic Forum (WEF), comprising top global enterprises.

After a thorough evaluation process, Transasia Bio-Medicals was selected as one of the most dynamic and high-growth companies, and considered a trailblazer, shaper, and innovator committed to improving the state of the world. This award also recognizes the strength of Transasia’s leadership ability.

The pool of candidates for 2014 was exceptionally strong and diverse, making the process all the more difficult and challenging. Transasia was selected in part on the basis of being one of the fast-growing companies with potential for global economic leadership. The nominated Global Growth Companies (GGCs) represent a broad cross-section of industry sectors but share a track record of exceeding industry standards in revenue growth, promotion of innovative business practices, and demonstration of leadership in corporate citizenship. Transasia Bio-Medicals being commended as India’s top manufacturer and exporter of diagnostic products to over 100 countries has been happily reckoned in this group.

The award was presented on November 5, 2014, at the India Economic Summit held in New Delhi, organized by WEF along with the Confederation of Indian Industry (CII). The summit facilitated the meeting of the WEF’s global multi-stakeholder community with the new government, to together define and help shape the country’s next phase of transformation. It enabled high-level leaders from the government, civil society, and the business sector to participate in issue-based interaction and explore how to collectively shape policies for inclusive growth. India’s Finance and Defence Minister, Mr. Arun Jaitley, inaugurated the summit.

Transasia Bio-Medicals is synonymous with quality and precision. It strives to deliver holistic healthcare solutions, thus providing its patrons with technological advances backed by expertise and experience. The company’s global footprint and mission are not only being recognized in India but also globally, and it takes pride in this acknowledgement by the prestigious World Economic Forum.

Related Links:

Transasia Bio-Medicals



New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
New
Sample Transportation System
Tempus1800 Necto
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.